Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel:
Von Willebrand Disease

Explore the latest updates and expert interviews

Welcome to the Von Willebrand Disease Channel

Discover the latest updates in VWD with VJHemOnc, which brings you exclusive video interviews with world-renowned experts, as well as podcasts and feature articles.

The VWD Channel covers the latest developments in the field, including novel therapies being explored, ongoing clinical trials, and more.

WM and the clinical implications of acquired von Willebrand syndrome 1:34
WM and the clinical implications of acquired von Willebrand syndrome
Karan Chohan • 28 Oct 2022
Challenges in vWD: new guidelines & managing women with vWD 1:23
Challenges in vWD: new guidelines & managing women with vWD
Susan Halimeh • 12 Jul 2022
Managing pregnant women with vWD 0:59
Managing pregnant women with vWD
Susan Halimeh • 11 Jul 2022
The diagnosis and management of bleeding disorders 2:47
The diagnosis and management of bleeding disorders
Gillian Lowe • 7 Apr 2022
Thromboprophylaxis in patients with VWD and COVID-19 2:06
Thromboprophylaxis in patients with VWD and COVID-19
Suchitra Acharya • 11 Oct 2021
Updates on the treatment of pediatric and AYA patients with MPNs 4:04
Updates on the treatment of pediatric and AYA patients with MPNs
Nicole Kucine • 10 Aug 2021
Case study: acquired von Willebrand disease in allogeneic BMT 1:23
Case study: acquired von Willebrand disease in allogeneic BMT
Pip Nicolson • 16 Apr 2018

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals